• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T-614 通过增加 Dlx5 表达和调节 p38 和 NF-B 的激活来促进成骨细胞分化。

T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-B.

机构信息

Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, 280 South Chongqing Road, Shanghai 200025, China.

Guanghua Rheumatology Hospital, 540 Xinhua Road, Shanghai 200052, China.

出版信息

Biomed Res Int. 2018 Feb 19;2018:4901591. doi: 10.1155/2018/4901591. eCollection 2018.

DOI:10.1155/2018/4901591
PMID:29670900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5836304/
Abstract

Rheumatoid arthritis (RA) is an autoimmune inflammatory disease characterized by bone loss. Degree of inflammation has been identified as an important initiator of skeletal damage in RA. Iguratimod (T-614) is an anti-inflammatory agent which has been reported to show the inhibitory effect of bone destruction in RA. However, the role of T-614 in osteoblast differentiation is still not clear. In this study, we intended to find the effect of T-614 on the osteogenesis process. We detected osteogenesis markers and transcription factors associated with osteoblastic lineage and bone formation in the culture of mesenchymal stem cells which differentiate osteoblast. The contents and activity of alkaline phosphatase, levels of collagen type I and bone gla protein, and calcium nodule formation were increased significantly after T-614 treated. Meanwhile, the mRNAs expressions of and were also found to be increased significantly by real-time PCR. The changes of levels of phosphorylation of p38 and NF-B were also detected by Western blot. The results showed that T-614 promotes osteoblastic differentiation by increasing the expression of and and increasing the activation of P38. T-614 could advance the ectopic expression of NF-B to suppress inflammation, which indirectly inhibits the damage of the osteoblasts.

摘要

类风湿关节炎(RA)是一种以骨丢失为特征的自身免疫性炎症性疾病。炎症程度已被确定为 RA 中骨骼破坏的重要启动因素。来氟米特(T-614)是一种具有抗炎作用的药物,据报道其具有抑制 RA 中骨破坏的作用。然而,T-614 在成骨细胞分化中的作用尚不清楚。在这项研究中,我们旨在研究 T-614 对成骨过程的影响。我们检测了间充质干细胞分化为成骨细胞的培养物中与成骨细胞谱系和骨形成相关的成骨标志物和转录因子。用 T-614 处理后,碱性磷酸酶的含量和活性、I 型胶原和骨钙素水平以及钙结节形成均显著增加。同时,实时 PCR 也发现 和 的 mRNAs 表达显著增加。通过 Western blot 还检测到 p38 和 NF-B 磷酸化水平的变化。结果表明,T-614 通过增加 和 的表达以及增加 P38 的激活来促进成骨细胞分化。T-614 可以促进 NF-B 的异位表达以抑制炎症,从而间接抑制成骨细胞的损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/b236d6989a39/BMRI2018-4901591.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/4a302b020b7c/BMRI2018-4901591.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/c64bc22e6158/BMRI2018-4901591.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/d55b48d152d6/BMRI2018-4901591.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/fe13c2b86cb0/BMRI2018-4901591.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/b236d6989a39/BMRI2018-4901591.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/4a302b020b7c/BMRI2018-4901591.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/c64bc22e6158/BMRI2018-4901591.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/d55b48d152d6/BMRI2018-4901591.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/fe13c2b86cb0/BMRI2018-4901591.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/332c/5836304/b236d6989a39/BMRI2018-4901591.005.jpg

相似文献

1
T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-B.T-614 通过增加 Dlx5 表达和调节 p38 和 NF-B 的激活来促进成骨细胞分化。
Biomed Res Int. 2018 Feb 19;2018:4901591. doi: 10.1155/2018/4901591. eCollection 2018.
2
Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.Gliotoxin通过抑制核因子-κB信号传导增强成骨细胞分化。
Mol Med Rep. 2015 Jul;12(1):877-84. doi: 10.3892/mmr.2015.3524. Epub 2015 Mar 20.
3
Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.乌冈宁 K 通过激活 p38 MAPK-和 ERK 介导的 Runx2 和骨钙素的表达促进成骨细胞分化和矿化。
Eur J Pharmacol. 2011 Oct 15;668(3):383-9. doi: 10.1016/j.ejphar.2011.06.059. Epub 2011 Jul 26.
4
Upregulated osterix expression elicited by Runx2 and Dlx5 is required for the accelerated osteoblast differentiation in PP2A Cα-knockdown cells.Runx2 和 Dlx5 上调的osterix 表达是 PP2A Cα 敲低细胞中加速成骨细胞分化所必需的。
Cell Biol Int. 2018 Apr;42(4):403-410. doi: 10.1002/cbin.10902. Epub 2017 Nov 15.
5
Sika pilose antler type I collagen promotes BMSC differentiation via the ERK1/2 and p38-MAPK signal pathways.梅花鹿鹿茸 I 型胶原蛋白通过 ERK1/2 和 p38-MAPK 信号通路促进骨髓间充质干细胞的分化。
Pharm Biol. 2017 Dec;55(1):2196-2204. doi: 10.1080/13880209.2017.1397177.
6
CD200 expression in human cultured bone marrow mesenchymal stem cells is induced by pro-osteogenic and pro-inflammatory cues.人培养骨髓间充质干细胞中的CD200表达由促骨生成和促炎信号诱导。
J Cell Mol Med. 2016 Apr;20(4):655-65. doi: 10.1111/jcmm.12752. Epub 2016 Jan 16.
7
Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation.原硅酸,Si(OH)4,通过上调miR-146a以拮抗NF-κB激活,在体外刺激成骨细胞分化。
Acta Biomater. 2016 Jul 15;39:192-202. doi: 10.1016/j.actbio.2016.05.007. Epub 2016 May 6.
8
A novel anti-rheumatic drug, T-614, stimulates osteoblastic differentiation in vitro and bone morphogenetic protein-2-induced bone formation in vivo.一种新型抗风湿药物T-614,在体外可刺激成骨细胞分化,在体内可促进骨形态发生蛋白-2诱导的骨形成。
Biochem Biophys Res Commun. 2002 Dec 20;299(5):903-9. doi: 10.1016/s0006-291x(02)02754-7.
9
5,6-Dehydrokawain from Alpinia zerumbet promotes osteoblastic MC3T3-E1 cell differentiation.艳山姜中的5,6-脱氢卡瓦因促进成骨MC3T3-E1细胞分化。
Biosci Biotechnol Biochem. 2016 Jul;80(7):1425-32. doi: 10.1080/09168451.2016.1153959. Epub 2016 Mar 4.
10
N-methyl pyrrolidone (NMP) ameliorates the hypoxia-reduced osteoblast differentiation via inhibiting the NF-κB signaling.N-甲基吡咯烷酮(NMP)通过抑制核因子κB(NF-κB)信号通路改善缺氧导致的成骨细胞分化减少。
J Toxicol Sci. 2016;41(5):701-9. doi: 10.2131/jts.41.701.

引用本文的文献

1
Melatonin attenuates degenerative disc degression by downregulating DLX5 via the TGF/Smad2/3 pathway in nucleus pulposus cells.褪黑素通过在髓核细胞中经由TGF/Smad2/3信号通路下调DLX5来减轻椎间盘退变。
JOR Spine. 2024 Nov 13;7(4):e70014. doi: 10.1002/jsp2.70014. eCollection 2024 Dec.
2
Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study.伊古曲妥单抗治疗肾移植后矿物质和骨代谢紊乱的疗效:一项初步研究。
Ren Fail. 2023;45(2):2256418. doi: 10.1080/0886022X.2023.2256418. Epub 2023 Oct 31.
3
Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases.

本文引用的文献

1
The Relationship Between Synovial Pathobiology and Magnetic Resonance Imaging Abnormalities in Rheumatoid Arthritis: A Systematic Review.类风湿关节炎滑膜病理生物学与磁共振成像异常的关系:系统评价。
J Rheumatol. 2017 Sep;44(9):1311-1324. doi: 10.3899/jrheum.161314. Epub 2017 Jul 15.
2
Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis.艾拉莫德对类风湿关节炎患者Th亚群平衡及炎性细胞因子的调控作用
Mediators Inflamm. 2015;2015:356040. doi: 10.1155/2015/356040. Epub 2015 Dec 2.
3
Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients.
依那西普治疗类风湿关节炎的临床疗效及安全性的Meta 分析
Front Immunol. 2023 Sep 21;14:1150661. doi: 10.3389/fimmu.2023.1150661. eCollection 2023.
4
The clinical characteristics and prognosis of patients with SAPHO syndrome--a real-world cohort study.SAPHO 综合征患者的临床特征和预后——一项真实世界的队列研究。
Clin Rheumatol. 2024 Jan;43(1):561-568. doi: 10.1007/s10067-023-06782-7. Epub 2023 Sep 27.
5
Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials.依那西普治疗强直性脊柱炎的疗效和安全性:系统评价和随机对照试验的荟萃分析。
Front Immunol. 2023 Mar 3;14:993860. doi: 10.3389/fimmu.2023.993860. eCollection 2023.
6
Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs.来氟米特单药或联合治疗类风湿关节炎患者的疗效:随机对照试验的系统评价和荟萃分析。
J Orthop Surg Res. 2021 Jul 16;16(1):457. doi: 10.1186/s13018-021-02603-2.
7
Iguratimod: Novel Molecular Insights and a New csDMARD for Rheumatoid Arthritis, from Japan to the World.艾拉莫德:类风湿关节炎新型分子机制及新型合成改善病情抗风湿药,从日本走向世界。
Life (Basel). 2021 May 20;11(5):457. doi: 10.3390/life11050457.
8
Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro.依阁瑞(iguratimod)对糖皮质激素诱导的体外骨代谢紊乱的影响。
J Bone Miner Metab. 2021 Jul;39(4):639-648. doi: 10.1007/s00774-021-01206-5. Epub 2021 Feb 9.
9
Efficacy and safety of iguratimod combined with methotrexate vs. methotrexate alone in rheumatoid arthritis : A systematic review and meta-analysis of randomized controlled trials.来氟米特联合甲氨蝶呤与甲氨蝶呤单药治疗类风湿关节炎的疗效和安全性:一项随机对照试验的系统评价和荟萃分析。
Z Rheumatol. 2021 Jun;80(5):432-446. doi: 10.1007/s00393-020-00944-7. Epub 2020 Dec 21.
10
Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19.小分子抑制剂在类风湿关节炎治疗中的应用及其他方面:最新进展和抗击 COVID-19 的潜在策略。
Cells. 2020 Aug 11;9(8):1876. doi: 10.3390/cells9081876.
新型抗风湿药物T-614对类风湿关节炎患者滑膜成纤维细胞中白细胞介素-6诱导的核因子κB受体活化因子配体/骨保护素、白细胞介素-17和基质金属蛋白酶-3表达的抑制作用
Biomed Res Int. 2015;2015:214683. doi: 10.1155/2015/214683. Epub 2015 Jul 27.
4
Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis.艾拉莫德在类风湿关节炎患者日常临床使用中52周的疗效。
Mod Rheumatol. 2015 Jul;25(4):534-9. doi: 10.3109/14397595.2014.998361. Epub 2015 Feb 11.
5
Efficacy of the clinical use of iguratimod therapy in patients with rheumatoid arthritis.艾拉莫德治疗类风湿关节炎患者的临床疗效。
Mod Rheumatol. 2015 Mar;25(2):235-40. doi: 10.3109/14397595.2014.938401. Epub 2014 Jul 28.
6
The cytokine-induced conformational switch of nuclear factor κB p65 is mediated by p65 phosphorylation.细胞因子诱导的核因子 κB p65 的构象转换是由 p65 磷酸化介导的。
Biochem J. 2014 Feb 1;457(3):401-13. doi: 10.1042/BJ20130780.
7
Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial.在甲氨蝶呤稳定剂量治疗下仍处于活动期的类风湿关节炎患者中联合使用来氟米特治疗:一项随机、双盲、安慰剂对照试验。
Mod Rheumatol. 2013 May;23(3):430-9. doi: 10.1007/s10165-012-0724-8. Epub 2012 Jul 26.
8
Autoimmune arthritis: the interface between the immune system and joints.自身免疫性关节炎:免疫系统与关节的接口。
Adv Immunol. 2012;115:45-71. doi: 10.1016/B978-0-12-394299-9.00002-3.
9
Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.和厚朴酚通过抑制 NF-κB 激活来刺激成骨细胞生成。
Int J Mol Med. 2011 Dec;28(6):1049-53. doi: 10.3892/ijmm.2011.786. Epub 2011 Aug 31.
10
Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells.针对炎症细胞因子和自身反应性 T 细胞的类风湿关节炎免疫疗法。
Arch Immunol Ther Exp (Warsz). 2010 Feb;58(1):27-36. doi: 10.1007/s00005-009-0058-1. Epub 2010 Jan 5.